nodes	percent_of_prediction	percent_of_DWPC	metapath
Amprenavir—ABCC1—Dactinomycin—testicular cancer	0.111	0.122	CbGbCtD
Amprenavir—ABCC1—Epirubicin—testicular cancer	0.0803	0.0882	CbGbCtD
Amprenavir—ABCC1—Vinblastine—testicular cancer	0.0695	0.0763	CbGbCtD
Amprenavir—ABCC1—Etoposide—testicular cancer	0.0626	0.0687	CbGbCtD
Amprenavir—CYP2B6—Ifosfamide—testicular cancer	0.0616	0.0677	CbGbCtD
Amprenavir—CYP3A5—Ifosfamide—testicular cancer	0.0485	0.0533	CbGbCtD
Amprenavir—CYP2C8—Ifosfamide—testicular cancer	0.0467	0.0512	CbGbCtD
Amprenavir—ABCC1—Doxorubicin—testicular cancer	0.0427	0.0469	CbGbCtD
Amprenavir—ABCC1—Methotrexate—testicular cancer	0.0413	0.0454	CbGbCtD
Amprenavir—CYP2C19—Ifosfamide—testicular cancer	0.0392	0.043	CbGbCtD
Amprenavir—CYP2C9—Ifosfamide—testicular cancer	0.0326	0.0357	CbGbCtD
Amprenavir—CYP2B6—Cisplatin—testicular cancer	0.03	0.0329	CbGbCtD
Amprenavir—ABCB1—Dactinomycin—testicular cancer	0.0268	0.0294	CbGbCtD
Amprenavir—CYP3A5—Etoposide—testicular cancer	0.0232	0.0255	CbGbCtD
Amprenavir—CYP2C8—Etoposide—testicular cancer	0.0223	0.0245	CbGbCtD
Amprenavir—CYP2B6—Doxorubicin—testicular cancer	0.0201	0.0221	CbGbCtD
Amprenavir—CYP3A4—Ifosfamide—testicular cancer	0.0189	0.0208	CbGbCtD
Amprenavir—ABCB1—Vinblastine—testicular cancer	0.0168	0.0184	CbGbCtD
Amprenavir—CYP2C9—Cisplatin—testicular cancer	0.0158	0.0174	CbGbCtD
Amprenavir—CYP2D6—Vinblastine—testicular cancer	0.0158	0.0173	CbGbCtD
Amprenavir—ABCB1—Cisplatin—testicular cancer	0.0154	0.0169	CbGbCtD
Amprenavir—ABCB1—Etoposide—testicular cancer	0.0151	0.0166	CbGbCtD
Amprenavir—ABCB1—Doxorubicin—testicular cancer	0.0103	0.0113	CbGbCtD
Amprenavir—CYP3A4—Vinblastine—testicular cancer	0.01	0.011	CbGbCtD
Amprenavir—ABCB1—Methotrexate—testicular cancer	0.00998	0.011	CbGbCtD
Amprenavir—CYP2D6—Doxorubicin—testicular cancer	0.0097	0.0107	CbGbCtD
Amprenavir—CYP3A4—Etoposide—testicular cancer	0.00905	0.00993	CbGbCtD
Amprenavir—CYP3A4—Doxorubicin—testicular cancer	0.00617	0.00677	CbGbCtD
Amprenavir—Liver function test abnormal—Dactinomycin—testicular cancer	0.000754	0.00845	CcSEcCtD
Amprenavir—Transaminases increased—Epirubicin—testicular cancer	0.00075	0.00841	CcSEcCtD
Amprenavir—Erythema multiforme—Chlorambucil—testicular cancer	0.00074	0.00829	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Dactinomycin—testicular cancer	0.000735	0.00824	CcSEcCtD
Amprenavir—Transaminases increased—Doxorubicin—testicular cancer	0.000694	0.00778	CcSEcCtD
Amprenavir—Acute coronary syndrome—Bleomycin—testicular cancer	0.000665	0.00745	CcSEcCtD
Amprenavir—Myocardial infarction—Bleomycin—testicular cancer	0.000661	0.00741	CcSEcCtD
Amprenavir—Neutropenia—Dactinomycin—testicular cancer	0.00066	0.0074	CcSEcCtD
Amprenavir—Tremor—Chlorambucil—testicular cancer	0.000638	0.00715	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Dactinomycin—testicular cancer	0.000624	0.00699	CcSEcCtD
Amprenavir—Angioedema—Chlorambucil—testicular cancer	0.000622	0.00698	CcSEcCtD
Amprenavir—Hyperglycaemia—Ifosfamide—testicular cancer	0.000583	0.00654	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Cisplatin—testicular cancer	0.000581	0.00651	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Ifosfamide—testicular cancer	0.000572	0.00641	CcSEcCtD
Amprenavir—Acute coronary syndrome—Ifosfamide—testicular cancer	0.000568	0.00637	CcSEcCtD
Amprenavir—Myocardial infarction—Ifosfamide—testicular cancer	0.000565	0.00633	CcSEcCtD
Amprenavir—Hepatobiliary disease—Ifosfamide—testicular cancer	0.000545	0.00611	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Methotrexate—testicular cancer	0.000536	0.00601	CcSEcCtD
Amprenavir—Abdominal discomfort—Cisplatin—testicular cancer	0.000534	0.00599	CcSEcCtD
Amprenavir—Erythema multiforme—Dactinomycin—testicular cancer	0.000534	0.00599	CcSEcCtD
Amprenavir—Anorexia—Chlorambucil—testicular cancer	0.00053	0.00594	CcSEcCtD
Amprenavir—Discomfort—Vinblastine—testicular cancer	0.000525	0.00588	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Etoposide—testicular cancer	0.000521	0.00584	CcSEcCtD
Amprenavir—Connective tissue disorder—Ifosfamide—testicular cancer	0.000509	0.0057	CcSEcCtD
Amprenavir—Inflammation—Methotrexate—testicular cancer	0.000503	0.00563	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Epirubicin—testicular cancer	0.000502	0.00562	CcSEcCtD
Amprenavir—Acute coronary syndrome—Cisplatin—testicular cancer	0.00049	0.00549	CcSEcCtD
Amprenavir—Erythema multiforme—Ifosfamide—testicular cancer	0.000489	0.00548	CcSEcCtD
Amprenavir—Myocardial infarction—Cisplatin—testicular cancer	0.000487	0.00546	CcSEcCtD
Amprenavir—Anorexia—Vinblastine—testicular cancer	0.000486	0.00544	CcSEcCtD
Amprenavir—Decreased appetite—Chlorambucil—testicular cancer	0.000483	0.00542	CcSEcCtD
Amprenavir—Cardiac disorder—Ifosfamide—testicular cancer	0.00048	0.00538	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.00048	0.00538	CcSEcCtD
Amprenavir—Fatigue—Chlorambucil—testicular cancer	0.000479	0.00537	CcSEcCtD
Amprenavir—Neutropenia—Etoposide—testicular cancer	0.000478	0.00535	CcSEcCtD
Amprenavir—Inflammation—Epirubicin—testicular cancer	0.00047	0.00527	CcSEcCtD
Amprenavir—Hepatobiliary disease—Cisplatin—testicular cancer	0.00047	0.00527	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Doxorubicin—testicular cancer	0.000464	0.0052	CcSEcCtD
Amprenavir—Paraesthesia—Vinblastine—testicular cancer	0.000457	0.00513	CcSEcCtD
Amprenavir—Gastrointestinal pain—Chlorambucil—testicular cancer	0.000455	0.00509	CcSEcCtD
Amprenavir—Mental disorder—Ifosfamide—testicular cancer	0.000453	0.00508	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Etoposide—testicular cancer	0.000451	0.00506	CcSEcCtD
Amprenavir—Malnutrition—Ifosfamide—testicular cancer	0.000451	0.00505	CcSEcCtD
Amprenavir—Acute coronary syndrome—Etoposide—testicular cancer	0.000449	0.00503	CcSEcCtD
Amprenavir—Myalgia—Bleomycin—testicular cancer	0.000449	0.00503	CcSEcCtD
Amprenavir—Myocardial infarction—Etoposide—testicular cancer	0.000446	0.005	CcSEcCtD
Amprenavir—Discomfort—Bleomycin—testicular cancer	0.000443	0.00497	CcSEcCtD
Amprenavir—Decreased appetite—Vinblastine—testicular cancer	0.000443	0.00496	CcSEcCtD
Amprenavir—Abdominal pain—Chlorambucil—testicular cancer	0.000439	0.00493	CcSEcCtD
Amprenavir—Connective tissue disorder—Cisplatin—testicular cancer	0.000438	0.00491	CcSEcCtD
Amprenavir—Inflammation—Doxorubicin—testicular cancer	0.000435	0.00488	CcSEcCtD
Amprenavir—Hepatobiliary disease—Etoposide—testicular cancer	0.000431	0.00483	CcSEcCtD
Amprenavir—Myalgia—Dactinomycin—testicular cancer	0.000419	0.00469	CcSEcCtD
Amprenavir—Gastrointestinal pain—Vinblastine—testicular cancer	0.000417	0.00467	CcSEcCtD
Amprenavir—Cardiac disorder—Cisplatin—testicular cancer	0.000414	0.00464	CcSEcCtD
Amprenavir—Discomfort—Dactinomycin—testicular cancer	0.000414	0.00464	CcSEcCtD
Amprenavir—Angioedema—Ifosfamide—testicular cancer	0.000412	0.00461	CcSEcCtD
Amprenavir—Anorexia—Bleomycin—testicular cancer	0.00041	0.0046	CcSEcCtD
Amprenavir—Diabetes mellitus—Methotrexate—testicular cancer	0.000407	0.00456	CcSEcCtD
Amprenavir—Abdominal pain—Vinblastine—testicular cancer	0.000403	0.00451	CcSEcCtD
Amprenavir—Asthenia—Chlorambucil—testicular cancer	0.000399	0.00447	CcSEcCtD
Amprenavir—Pruritus—Chlorambucil—testicular cancer	0.000393	0.00441	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.000392	0.00439	CcSEcCtD
Amprenavir—Malnutrition—Cisplatin—testicular cancer	0.000388	0.00435	CcSEcCtD
Amprenavir—Erythema multiforme—Etoposide—testicular cancer	0.000386	0.00433	CcSEcCtD
Amprenavir—Paraesthesia—Bleomycin—testicular cancer	0.000386	0.00433	CcSEcCtD
Amprenavir—Myalgia—Ifosfamide—testicular cancer	0.000384	0.0043	CcSEcCtD
Amprenavir—Flatulence—Cisplatin—testicular cancer	0.000383	0.00429	CcSEcCtD
Amprenavir—Anorexia—Dactinomycin—testicular cancer	0.000382	0.00429	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.000381	0.00427	CcSEcCtD
Amprenavir—Diabetes mellitus—Epirubicin—testicular cancer	0.000381	0.00427	CcSEcCtD
Amprenavir—Diarrhoea—Chlorambucil—testicular cancer	0.00038	0.00426	CcSEcCtD
Amprenavir—Cardiac disorder—Etoposide—testicular cancer	0.000379	0.00425	CcSEcCtD
Amprenavir—Discomfort—Ifosfamide—testicular cancer	0.000379	0.00425	CcSEcCtD
Amprenavir—Decreased appetite—Bleomycin—testicular cancer	0.000374	0.00419	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.000366	0.0041	CcSEcCtD
Amprenavir—Asthenia—Vinblastine—testicular cancer	0.000365	0.0041	CcSEcCtD
Amprenavir—Tremor—Cisplatin—testicular cancer	0.000364	0.00408	CcSEcCtD
Amprenavir—Nervous system disorder—Ifosfamide—testicular cancer	0.000361	0.00404	CcSEcCtD
Amprenavir—Skin disorder—Ifosfamide—testicular cancer	0.000357	0.004	CcSEcCtD
Amprenavir—Vomiting—Chlorambucil—testicular cancer	0.000353	0.00396	CcSEcCtD
Amprenavir—Diabetes mellitus—Doxorubicin—testicular cancer	0.000352	0.00395	CcSEcCtD
Amprenavir—Anorexia—Ifosfamide—testicular cancer	0.00035	0.00393	CcSEcCtD
Amprenavir—Decreased appetite—Dactinomycin—testicular cancer	0.000349	0.00391	CcSEcCtD
Amprenavir—Diarrhoea—Vinblastine—testicular cancer	0.000349	0.00391	CcSEcCtD
Amprenavir—Fatigue—Dactinomycin—testicular cancer	0.000346	0.00388	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000335	0.00375	CcSEcCtD
Amprenavir—Myalgia—Cisplatin—testicular cancer	0.000331	0.00371	CcSEcCtD
Amprenavir—Nausea—Chlorambucil—testicular cancer	0.00033	0.0037	CcSEcCtD
Amprenavir—Paraesthesia—Ifosfamide—testicular cancer	0.00033	0.0037	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.000328	0.00368	CcSEcCtD
Amprenavir—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000328	0.00368	CcSEcCtD
Amprenavir—Liver function test abnormal—Methotrexate—testicular cancer	0.000327	0.00366	CcSEcCtD
Amprenavir—Discomfort—Cisplatin—testicular cancer	0.000327	0.00366	CcSEcCtD
Amprenavir—Vomiting—Vinblastine—testicular cancer	0.000324	0.00363	CcSEcCtD
Amprenavir—Decreased appetite—Ifosfamide—testicular cancer	0.00032	0.00358	CcSEcCtD
Amprenavir—Headache—Vinblastine—testicular cancer	0.000319	0.00358	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000317	0.00356	CcSEcCtD
Amprenavir—Abdominal pain—Dactinomycin—testicular cancer	0.000317	0.00356	CcSEcCtD
Amprenavir—Fatigue—Ifosfamide—testicular cancer	0.000317	0.00355	CcSEcCtD
Amprenavir—Nervous system disorder—Cisplatin—testicular cancer	0.000311	0.00348	CcSEcCtD
Amprenavir—Asthenia—Bleomycin—testicular cancer	0.000309	0.00346	CcSEcCtD
Amprenavir—Skin disorder—Cisplatin—testicular cancer	0.000308	0.00345	CcSEcCtD
Amprenavir—Liver function test abnormal—Epirubicin—testicular cancer	0.000306	0.00343	CcSEcCtD
Amprenavir—Pruritus—Bleomycin—testicular cancer	0.000304	0.00341	CcSEcCtD
Amprenavir—Nausea—Vinblastine—testicular cancer	0.000303	0.00339	CcSEcCtD
Amprenavir—Anorexia—Cisplatin—testicular cancer	0.000302	0.00339	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000301	0.00337	CcSEcCtD
Amprenavir—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000301	0.00337	CcSEcCtD
Amprenavir—Discomfort—Etoposide—testicular cancer	0.000299	0.00335	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Epirubicin—testicular cancer	0.000298	0.00334	CcSEcCtD
Amprenavir—Abdominal discomfort—Methotrexate—testicular cancer	0.000293	0.00329	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Epirubicin—testicular cancer	0.000292	0.00327	CcSEcCtD
Amprenavir—Abdominal pain—Ifosfamide—testicular cancer	0.000291	0.00326	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000289	0.00324	CcSEcCtD
Amprenavir—Asthenia—Dactinomycin—testicular cancer	0.000288	0.00323	CcSEcCtD
Amprenavir—Neutropenia—Methotrexate—testicular cancer	0.000286	0.00321	CcSEcCtD
Amprenavir—Paraesthesia—Cisplatin—testicular cancer	0.000285	0.00319	CcSEcCtD
Amprenavir—Liver function test abnormal—Doxorubicin—testicular cancer	0.000283	0.00317	CcSEcCtD
Amprenavir—Skin disorder—Etoposide—testicular cancer	0.000282	0.00316	CcSEcCtD
Amprenavir—Anorexia—Etoposide—testicular cancer	0.000277	0.0031	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	0.000276	0.00309	CcSEcCtD
Amprenavir—Decreased appetite—Cisplatin—testicular cancer	0.000276	0.00309	CcSEcCtD
Amprenavir—Diarrhoea—Dactinomycin—testicular cancer	0.000275	0.00308	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000274	0.00307	CcSEcCtD
Amprenavir—Vomiting—Bleomycin—testicular cancer	0.000274	0.00307	CcSEcCtD
Amprenavir—Depression—Methotrexate—testicular cancer	0.000272	0.00305	CcSEcCtD
Amprenavir—Rash—Bleomycin—testicular cancer	0.000271	0.00304	CcSEcCtD
Amprenavir—Dermatitis—Bleomycin—testicular cancer	0.000271	0.00304	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.00027	0.00303	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.00027	0.00303	CcSEcCtD
Amprenavir—Neutropenia—Epirubicin—testicular cancer	0.000268	0.003	CcSEcCtD
Amprenavir—Asthenia—Ifosfamide—testicular cancer	0.000264	0.00296	CcSEcCtD
Amprenavir—Paraesthesia—Etoposide—testicular cancer	0.000261	0.00292	CcSEcCtD
Amprenavir—Pruritus—Ifosfamide—testicular cancer	0.00026	0.00292	CcSEcCtD
Amprenavir—Hyperglycaemia—Epirubicin—testicular cancer	0.000258	0.00289	CcSEcCtD
Amprenavir—Hepatobiliary disease—Methotrexate—testicular cancer	0.000258	0.00289	CcSEcCtD
Amprenavir—Nausea—Bleomycin—testicular cancer	0.000256	0.00286	CcSEcCtD
Amprenavir—Vomiting—Dactinomycin—testicular cancer	0.000255	0.00286	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000253	0.00284	CcSEcCtD
Amprenavir—Rash—Dactinomycin—testicular cancer	0.000253	0.00284	CcSEcCtD
Amprenavir—Decreased appetite—Etoposide—testicular cancer	0.000252	0.00283	CcSEcCtD
Amprenavir—Diarrhoea—Ifosfamide—testicular cancer	0.000252	0.00282	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Etoposide—testicular cancer	0.000251	0.00281	CcSEcCtD
Amprenavir—Fatigue—Etoposide—testicular cancer	0.00025	0.00281	CcSEcCtD
Amprenavir—Neutropenia—Doxorubicin—testicular cancer	0.000248	0.00278	CcSEcCtD
Amprenavir—Hepatobiliary disease—Epirubicin—testicular cancer	0.000241	0.00271	CcSEcCtD
Amprenavir—Hyperglycaemia—Doxorubicin—testicular cancer	0.000239	0.00268	CcSEcCtD
Amprenavir—Nausea—Dactinomycin—testicular cancer	0.000238	0.00267	CcSEcCtD
Amprenavir—Gastrointestinal pain—Etoposide—testicular cancer	0.000237	0.00266	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000234	0.00262	CcSEcCtD
Amprenavir—Vomiting—Ifosfamide—testicular cancer	0.000234	0.00262	CcSEcCtD
Amprenavir—Rash—Ifosfamide—testicular cancer	0.000232	0.0026	CcSEcCtD
Amprenavir—Dermatitis—Ifosfamide—testicular cancer	0.000232	0.0026	CcSEcCtD
Amprenavir—Erythema multiforme—Methotrexate—testicular cancer	0.000231	0.00259	CcSEcCtD
Amprenavir—Abdominal pain—Etoposide—testicular cancer	0.00023	0.00257	CcSEcCtD
Amprenavir—Asthenia—Cisplatin—testicular cancer	0.000227	0.00255	CcSEcCtD
Amprenavir—Cardiac disorder—Methotrexate—testicular cancer	0.000227	0.00255	CcSEcCtD
Amprenavir—Connective tissue disorder—Epirubicin—testicular cancer	0.000225	0.00252	CcSEcCtD
Amprenavir—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000223	0.0025	CcSEcCtD
Amprenavir—Nausea—Ifosfamide—testicular cancer	0.000218	0.00245	CcSEcCtD
Amprenavir—Diarrhoea—Cisplatin—testicular cancer	0.000217	0.00243	CcSEcCtD
Amprenavir—Erythema multiforme—Epirubicin—testicular cancer	0.000217	0.00243	CcSEcCtD
Amprenavir—Mental disorder—Methotrexate—testicular cancer	0.000214	0.0024	CcSEcCtD
Amprenavir—Malnutrition—Methotrexate—testicular cancer	0.000213	0.00239	CcSEcCtD
Amprenavir—Cardiac disorder—Epirubicin—testicular cancer	0.000213	0.00238	CcSEcCtD
Amprenavir—Asthenia—Etoposide—testicular cancer	0.000208	0.00234	CcSEcCtD
Amprenavir—Connective tissue disorder—Doxorubicin—testicular cancer	0.000208	0.00234	CcSEcCtD
Amprenavir—Pruritus—Etoposide—testicular cancer	0.000205	0.0023	CcSEcCtD
Amprenavir—Vomiting—Cisplatin—testicular cancer	0.000202	0.00226	CcSEcCtD
Amprenavir—Mental disorder—Epirubicin—testicular cancer	0.000201	0.00225	CcSEcCtD
Amprenavir—Erythema multiforme—Doxorubicin—testicular cancer	0.0002	0.00225	CcSEcCtD
Amprenavir—Rash—Cisplatin—testicular cancer	0.0002	0.00224	CcSEcCtD
Amprenavir—Dermatitis—Cisplatin—testicular cancer	0.0002	0.00224	CcSEcCtD
Amprenavir—Malnutrition—Epirubicin—testicular cancer	0.000199	0.00224	CcSEcCtD
Amprenavir—Diarrhoea—Etoposide—testicular cancer	0.000199	0.00223	CcSEcCtD
Amprenavir—Cardiac disorder—Doxorubicin—testicular cancer	0.000197	0.00221	CcSEcCtD
Amprenavir—Flatulence—Epirubicin—testicular cancer	0.000197	0.0022	CcSEcCtD
Amprenavir—Nausea—Cisplatin—testicular cancer	0.000188	0.00211	CcSEcCtD
Amprenavir—Mental disorder—Doxorubicin—testicular cancer	0.000186	0.00208	CcSEcCtD
Amprenavir—Vomiting—Etoposide—testicular cancer	0.000185	0.00207	CcSEcCtD
Amprenavir—Malnutrition—Doxorubicin—testicular cancer	0.000185	0.00207	CcSEcCtD
Amprenavir—Rash—Etoposide—testicular cancer	0.000183	0.00205	CcSEcCtD
Amprenavir—Dermatitis—Etoposide—testicular cancer	0.000183	0.00205	CcSEcCtD
Amprenavir—Headache—Etoposide—testicular cancer	0.000182	0.00204	CcSEcCtD
Amprenavir—Flatulence—Doxorubicin—testicular cancer	0.000182	0.00204	CcSEcCtD
Amprenavir—Myalgia—Methotrexate—testicular cancer	0.000181	0.00203	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00018	0.00202	CcSEcCtD
Amprenavir—Discomfort—Methotrexate—testicular cancer	0.000179	0.00201	CcSEcCtD
Amprenavir—Nausea—Etoposide—testicular cancer	0.000172	0.00193	CcSEcCtD
Amprenavir—Nervous system disorder—Methotrexate—testicular cancer	0.000171	0.00191	CcSEcCtD
Amprenavir—Myalgia—Epirubicin—testicular cancer	0.00017	0.0019	CcSEcCtD
Amprenavir—Skin disorder—Methotrexate—testicular cancer	0.000169	0.00189	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000169	0.00189	CcSEcCtD
Amprenavir—Discomfort—Epirubicin—testicular cancer	0.000168	0.00188	CcSEcCtD
Amprenavir—Anorexia—Methotrexate—testicular cancer	0.000166	0.00186	CcSEcCtD
Amprenavir—Nervous system disorder—Epirubicin—testicular cancer	0.00016	0.00179	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000158	0.00178	CcSEcCtD
Amprenavir—Skin disorder—Epirubicin—testicular cancer	0.000158	0.00177	CcSEcCtD
Amprenavir—Myalgia—Doxorubicin—testicular cancer	0.000157	0.00176	CcSEcCtD
Amprenavir—Paraesthesia—Methotrexate—testicular cancer	0.000156	0.00175	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000156	0.00175	CcSEcCtD
Amprenavir—Discomfort—Doxorubicin—testicular cancer	0.000155	0.00174	CcSEcCtD
Amprenavir—Anorexia—Epirubicin—testicular cancer	0.000155	0.00174	CcSEcCtD
Amprenavir—Decreased appetite—Methotrexate—testicular cancer	0.000151	0.00169	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Methotrexate—testicular cancer	0.00015	0.00168	CcSEcCtD
Amprenavir—Fatigue—Methotrexate—testicular cancer	0.00015	0.00168	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000148	0.00166	CcSEcCtD
Amprenavir—Nervous system disorder—Doxorubicin—testicular cancer	0.000148	0.00166	CcSEcCtD
Amprenavir—Skin disorder—Doxorubicin—testicular cancer	0.000146	0.00164	CcSEcCtD
Amprenavir—Paraesthesia—Epirubicin—testicular cancer	0.000146	0.00164	CcSEcCtD
Amprenavir—Anorexia—Doxorubicin—testicular cancer	0.000144	0.00161	CcSEcCtD
Amprenavir—Gastrointestinal pain—Methotrexate—testicular cancer	0.000142	0.00159	CcSEcCtD
Amprenavir—Decreased appetite—Epirubicin—testicular cancer	0.000142	0.00159	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000141	0.00158	CcSEcCtD
Amprenavir—Fatigue—Epirubicin—testicular cancer	0.00014	0.00157	CcSEcCtD
Amprenavir—Abdominal pain—Methotrexate—testicular cancer	0.000138	0.00154	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000137	0.00154	CcSEcCtD
Amprenavir—Paraesthesia—Doxorubicin—testicular cancer	0.000135	0.00152	CcSEcCtD
Amprenavir—Gastrointestinal pain—Epirubicin—testicular cancer	0.000133	0.00149	CcSEcCtD
Amprenavir—Decreased appetite—Doxorubicin—testicular cancer	0.000131	0.00147	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.00013	0.00146	CcSEcCtD
Amprenavir—Fatigue—Doxorubicin—testicular cancer	0.00013	0.00146	CcSEcCtD
Amprenavir—Abdominal pain—Epirubicin—testicular cancer	0.000129	0.00144	CcSEcCtD
Amprenavir—Asthenia—Methotrexate—testicular cancer	0.000125	0.0014	CcSEcCtD
Amprenavir—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000123	0.00138	CcSEcCtD
Amprenavir—Pruritus—Methotrexate—testicular cancer	0.000123	0.00138	CcSEcCtD
Amprenavir—Abdominal pain—Doxorubicin—testicular cancer	0.000119	0.00133	CcSEcCtD
Amprenavir—Diarrhoea—Methotrexate—testicular cancer	0.000119	0.00133	CcSEcCtD
Amprenavir—Asthenia—Epirubicin—testicular cancer	0.000117	0.00131	CcSEcCtD
Amprenavir—Pruritus—Epirubicin—testicular cancer	0.000115	0.00129	CcSEcCtD
Amprenavir—Diarrhoea—Epirubicin—testicular cancer	0.000111	0.00125	CcSEcCtD
Amprenavir—Vomiting—Methotrexate—testicular cancer	0.000111	0.00124	CcSEcCtD
Amprenavir—Rash—Methotrexate—testicular cancer	0.00011	0.00123	CcSEcCtD
Amprenavir—Dermatitis—Methotrexate—testicular cancer	0.00011	0.00123	CcSEcCtD
Amprenavir—Headache—Methotrexate—testicular cancer	0.000109	0.00122	CcSEcCtD
Amprenavir—Asthenia—Doxorubicin—testicular cancer	0.000108	0.00121	CcSEcCtD
Amprenavir—Pruritus—Doxorubicin—testicular cancer	0.000107	0.00119	CcSEcCtD
Amprenavir—Vomiting—Epirubicin—testicular cancer	0.000103	0.00116	CcSEcCtD
Amprenavir—Nausea—Methotrexate—testicular cancer	0.000103	0.00116	CcSEcCtD
Amprenavir—Diarrhoea—Doxorubicin—testicular cancer	0.000103	0.00116	CcSEcCtD
Amprenavir—Rash—Epirubicin—testicular cancer	0.000103	0.00115	CcSEcCtD
Amprenavir—Dermatitis—Epirubicin—testicular cancer	0.000103	0.00115	CcSEcCtD
Amprenavir—Headache—Epirubicin—testicular cancer	0.000102	0.00114	CcSEcCtD
Amprenavir—Nausea—Epirubicin—testicular cancer	9.67e-05	0.00108	CcSEcCtD
Amprenavir—Vomiting—Doxorubicin—testicular cancer	9.58e-05	0.00107	CcSEcCtD
Amprenavir—Rash—Doxorubicin—testicular cancer	9.5e-05	0.00106	CcSEcCtD
Amprenavir—Dermatitis—Doxorubicin—testicular cancer	9.49e-05	0.00106	CcSEcCtD
Amprenavir—Headache—Doxorubicin—testicular cancer	9.44e-05	0.00106	CcSEcCtD
Amprenavir—Nausea—Doxorubicin—testicular cancer	8.95e-05	0.001	CcSEcCtD
